Yes. Lung cancer screening can detect cancer before symptoms appear—and finding it early may give patients more treatment options and a better chance of survival.
Lung cancer is often difficult to detect in its earliest stages because it may not cause noticeable symptoms. A person can feel healthy, have no persistent cough, and still have an early lung cancer developing.
That is why lung cancer screening is so important for people at increased risk.
What Is Lung Cancer Screening?
Lung cancer screening is a test used to look for lung cancer in people who do not have symptoms.
The recommended screening test is a low-dose computed tomography scan, commonly called a low-dose CT or LDCT.
During the scan:
- You lie on a table that moves through a CT scanner.
- The scanner uses a low dose of X-ray radiation to create detailed images of your lungs.
- The scan usually takes only a few minutes.
- It does not require an incision or anesthesia.
- You can generally return to your normal activities immediately afterward.
Unlike a standard chest X-ray, a low-dose CT scan can detect smaller abnormalities in the lungs. Some of these abnormalities may represent early lung cancer.
The goal is to identify cancer before it causes symptoms, when it may be easier to treat successfully.
Why Finding Lung Cancer Early Matters
Lung cancer treatment depends on several factors, including the type of cancer, its stage, the patient’s overall health, and the location of the tumor.
When lung cancer is discovered at an early stage, it may be possible to remove it surgically before it spreads to other parts of the body.
Depending on the situation, treatment may include:
- Surgery to remove the tumor.
- Radiation therapy.
- Chemotherapy.
- Immunotherapy.
- Targeted therapies for cancers with specific genetic changes.
For some patients with early-stage non-small cell lung cancer, surgery may offer the possibility of long-term disease-free survival or cure.
However, not every lung cancer can be cured, even when it is detected early. Screening improves the opportunity for early diagnosis; it does not guarantee a cure.
What Does the Scientific Evidence Show?
One of the most important studies in lung cancer screening is the National Lung Screening Trial, or NLST.
The study was a large, randomized clinical trial conducted in the United States. It included more than 53,000 adults who were at high risk for lung cancer because of their age and smoking history.
Participants were assigned to receive either:
- Annual low-dose CT scans of the chest.
- Annual standard chest X-rays.
The researchers compared the number of lung cancer deaths in the two groups.
What Did the National Lung Screening Trial Find?
The results, published in the New England Journal of Medicine in 2011, showed that participants screened with low-dose CT had a 20% relative reduction in lung cancer mortality compared with those screened with chest X-rays.
The study also found a reduction in deaths from any cause.
These findings were important because they provided strong evidence that low-dose CT screening could do more than identify lung abnormalities. It could help save lives by detecting lung cancer earlier.
Study Reference
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening.
National Lung Screening Trial Research Team. The New England Journal of Medicine. 2011;365:395–409.
DOI: 10.1056/NEJMoa1102873
What Has More Recent Research Shown?
Research published since the original NLST has continued to evaluate the benefits, limitations, and practical challenges of lung cancer screening.
A 2025 review by Grenier and colleagues, titled Low Dose CT for Lung Cancer Screening, examined the evidence supporting organized screening programs.
The review highlighted findings from two major randomized trials:
- The National Lung Screening Trial in the United States.
- The NELSON trial in Europe.
Both trials found that low-dose CT screening can reduce lung cancer mortality in appropriately selected people at high risk.
The research also emphasizes that screening programs need to identify eligible patients, ensure regular follow-up, and provide appropriate evaluation of suspicious findings.
Screening works best when it is part of an organized process—not simply a single CT scan with no follow-up.
Study Reference
Grenier PA, et al. Low dose CT for lung cancer screening. Journal of Thoracic Disease. 2025.
Who Should Get Screened for Lung Cancer?
In the United States, the U.S. Preventive Services Task Force recommends annual low-dose CT screening for adults who meet all of the following criteria:
- They are between 50 and 80 years old.
- They have at least a 20 pack-year smoking history.
- They currently smoke or quit smoking within the past 15 years.
- They are healthy enough to undergo treatment if lung cancer is found.
A pack-year is a way to measure a person’s smoking history.
For example:
- Smoking one pack of cigarettes per day for 20 years equals 20 pack-years.
- Smoking two packs per day for 10 years also equals 20 pack-years.
- Smoking half a pack per day for 40 years equals 20 pack-years.
Screening recommendations may change as new evidence becomes available. Your physician can help determine whether you meet current screening criteria.
Can Non-Smokers Get Lung Cancer?
Yes. People who have never smoked can develop lung cancer.
Risk factors may include:
- Exposure to secondhand smoke.
- Radon exposure.
- Occupational exposure to certain substances.
- Air pollution.
- Family history and other individual risk factors.
However, routine low-dose CT screening is not currently recommended for everyone who has never smoked.
The evidence supporting screening is strongest for people at high risk based on established criteria. Screening people at lower risk can lead to false alarms, unnecessary testing, radiation exposure, and other potential harms.
If you have concerns about your personal risk, discuss them with your physician.
What Happens If a Screening CT Finds a Lung Nodule?
A lung nodule is a small area of abnormal tissue in the lung. Nodules are relatively common, especially in people who have smoked or who have had previous infections or inflammation.
A lung nodule does not automatically mean cancer.
When a nodule is discovered, doctors consider several factors:
- Its size.
- Its shape and appearance.
- Whether it is solid or partly solid.
- Its location in the lung.
- Whether it has changed over time.
- Your age and medical history.
- Your smoking history and other risk factors.
Depending on the findings, the next step may be a follow-up CT scan, additional imaging, a biopsy, or a referral to a specialist.
Some nodules can be safely monitored. Others may require more immediate evaluation.
The important point is that an abnormal screening result is not the same as a cancer diagnosis.
Are There Risks to Lung Cancer Screening?
Like any medical test, low-dose CT screening has benefits and limitations.
Potential concerns include:
False-positive results
A scan may identify a suspicious area that turns out not to be cancer. This can lead to additional imaging, anxiety, and sometimes invasive procedures.
Radiation exposure
Low-dose CT uses less radiation than a standard diagnostic chest CT, but it still involves radiation. The potential benefit of screening must be weighed against the risks.
Overdiagnosis
Some cancers detected through screening may grow so slowly that they would never have caused symptoms or threatened a person’s life. Detecting and treating these cancers can expose patients to unnecessary harm.
Follow-up requirements
Screening is not a one-time test for most eligible patients. Annual screening and appropriate follow-up are important parts of the process.
The goal is to maximize the number of dangerous cancers found early while minimizing unnecessary procedures.
Does Lung Cancer Screening Replace Paying Attention to Symptoms?
No.
Even if you receive regular screening, you should not ignore new or persistent symptoms.
Contact your physician if you experience symptoms such as:
- A persistent or worsening cough.
- Coughing up blood.
- Unexplained weight loss.
- Chest pain.
- Shortness of breath.
- Persistent hoarseness.
- Recurrent respiratory infections.
These symptoms can have many causes, and they do not necessarily mean you have lung cancer. However, they deserve appropriate medical evaluation.
Screening is intended for people without symptoms. When symptoms are present, your physician may recommend diagnostic testing rather than waiting for a routine screening scan.
The Bottom Line
Lung cancer screening can find cancer before symptoms appear. Strong clinical evidence shows that annual low-dose CT screening reduces lung cancer deaths among appropriately selected adults at high risk.
The National Lung Screening Trial demonstrated a 20% relative reduction in lung cancer mortality compared with chest X-ray screening. More recent research continues to support the value of well-organized screening programs.
If you are between 50 and 80 years old and have a significant smoking history, ask your physician whether you qualify for annual low-dose CT screening.
Early detection can make a meaningful difference. Knowing your risk and taking the right steps at the right time may help identify lung cancer when treatment has the greatest potential to succeed.
Medical Disclaimer: This article is for educational purposes only and is not a substitute for personalized medical advice, diagnosis, or treatment. Lung cancer screening decisions should be made with a qualified healthcare professional based on your individual risk factors, health status, and current screening recommendations.